G6PD Cancer Research Results
G6PD, Glucose-6-phosphate dehydrogenase: Click to Expand ⟱
| Source: |
| Type: |
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that plays a crucial role in the pentose phosphate pathway (PPP), a metabolic pathway that generates NADPH and pentoses from glucose-6-phosphate. G6PD is the first enzyme in the PPP and is responsible for catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconate, producing NADPH in the process.
**** patients who receive intravenous ascorbate must be prescreened for glucose 6 phosphate dehydrogenase deficiency.
G6PD expression is often elevated in various cancers and is generally linked to poorer prognosis.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
TumCI↓, G6PD↓, HK2↓, Glycolysis↓,
G6PD↓, PCNA↓, cycD1/CCND1↓, P21↑, Hif1a↓, Glycolysis↓,
Glycolysis↓, GLUT1↓, PFK1↓, Hif1a↓, ROS↑, PDH↑, AMPK↑, TumCG↓, TumCI↓, TumCP↓, p‑NF-kB↓, SIRT1↑, SIRT3↑, LDH↓, PI3K↓, mTOR↓, PKM2↓, R5P↝, G6PD↓, TKT↝, talin↓, HK2↓, GRP78/BiP↑, GlucoseCon↓, ER Stress↑, Warburg↓, PFK↓,
*neuroP↑, *BioAv↓, *Half-Life↓, *BioAv↑, *BBB↑, *NRF2↑, *BioAv↓, *BioAv↑, *SIRT1↑, *cognitive↑, *lipid-P↓, *HO-1↑, *SOD↑, *GSH↑, *GPx↑, *G6PD↑, *PPARγ↑, *AMPK↑, *Aβ↓,
*GlucoseCon↓, *ROS↓, *Trx↓, *HK2↓, *NRF2↑, *Catalase↑, *TXNIP↑, *PFKFB2↓, *G6PD↑,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vivo, |
GBM, |
NA |
|
|
|
- |
in-vitro, |
GBM, |
U251 |
|
|
|
RIP1↑, RIP3↑, Glycolysis↓, G6PD↓, HK2↓, PKM2↓, H2O2↑, GSH↓, ROS↑,
*neuroP↑, *Inflam↓, *ATP↑, *G6PD↑, *NADPH↑, *IL1β↓, *other↝,
H2O2↑, ROS↑, TET1↑, DNAdam↑, G6PD∅,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↓, 1, H2O2↑, 2, ROS↑, 3, SIRT3↑, 1, TKT↝, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, G6PD↓, 4, G6PD∅, 1, GlucoseCon↓, 1, Glycolysis↓, 4, HK2↓, 3, LDH↓, 1, PDH↑, 1, PFK↓, 1, PFK1↓, 1, PKM2↓, 2, R5P↝, 1, SIRT1↑, 1, Warburg↓, 1,
Cell Death ⓘ
RIP1↑, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1, GRP78/BiP↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 1,
Proliferation, Differentiation & Cell State ⓘ
mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
RIP3↑, 1, talin↓, 1, TET1↑, 1, TumCI↓, 2, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 2,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
p‑NF-kB↓, 1,
Clinical Biomarkers ⓘ
LDH↓, 1,
Total Targets: 38
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GPx↑, 1, GSH↑, 1, HO-1↑, 1, lipid-P↓, 1, NRF2↑, 2, ROS↓, 1, SOD↑, 1, Trx↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, G6PD↑, 3, GlucoseCon↓, 1, HK2↓, 1, NADPH↑, 1, PFKFB2↓, 1, PPARγ↑, 1, SIRT1↑, 1,
Transcription & Epigenetics ⓘ
other↝, 1,
Migration ⓘ
TXNIP↑, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, Inflam↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 2, Half-Life↓, 1,
Functional Outcomes ⓘ
cognitive↑, 1, neuroP↑, 2,
Total Targets: 29
Scientific Paper Hit Count for: G6PD, Glucose-6-phosphate dehydrogenase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:808 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page